Filing Details

Accession Number:
0001628280-19-011195
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-26 19:42:14
Reporting Period:
2019-08-22
Accepted Time:
2019-08-26 19:42:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576280 Guardant Health Inc. GH Services-Medical Laboratories (8071) 454139254
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753159 Amirali Talasaz 505 Penobscot Drive
Redwood City CA 94063
Chairman, President And Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-22 11,489 $4.18 13,196 No 4 M Direct
Common Stock Disposition 2019-08-22 1,762 $96.29 11,434 No 4 S Direct
Common Stock Disposition 2019-08-22 2,681 $97.12 8,753 No 4 S Direct
Common Stock Disposition 2019-08-22 3,965 $98.15 4,788 No 4 S Direct
Common Stock Disposition 2019-08-22 2,752 $98.97 2,036 No 4 S Direct
Common Stock Disposition 2019-08-22 420 $99.97 1,616 No 4 S Direct
Common Stock Disposition 2019-08-22 25 $102.02 1,591 No 4 S Direct
Common Stock Disposition 2019-08-22 4,935 $96.29 3,669,323 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-22 7,507 $97.12 3,661,816 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-22 11,075 $98.15 3,650,741 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-22 7,704 $98.97 3,643,037 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-22 1,180 $99.97 3,641,857 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-22 69 $102.02 3,641,788 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-22 137 $96.29 11,291 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-22 203 $97.10 11,088 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-22 286 $98.17 10,802 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-22 211 $98.97 10,591 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-22 34 $99.96 10,557 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-22 2 $102.02 10,555 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-22 137 $96.29 11,291 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-22 203 $97.10 11,088 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-22 285 $98.17 10,803 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-22 211 $98.97 10,592 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-22 34 $99.96 10,558 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-22 2 $102.02 10,556 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Acquisiton 2019-08-23 8,865 $4.18 10,456 No 4 M Direct
Common Stock Disposition 2019-08-23 2,237 $94.79 8,219 No 4 S Direct
Common Stock Disposition 2019-08-23 2,342 $95.53 5,877 No 4 S Direct
Common Stock Disposition 2019-08-23 1,127 $96.76 4,750 No 4 S Direct
Common Stock Disposition 2019-08-23 1,189 $97.72 3,561 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2019-08-22 11,489 $0.00 11,489 $4.18
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2019-08-23 8,865 $0.00 8,865 $4.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,095,436 2022-07-13 No 4 M Direct
1,086,571 2022-07-13 No 4 M Direct
Footnotes
  1. These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.59 to $96.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.62 to $97.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.63 to $98.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.63 to $99.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.69 to $100.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.12 to $95.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.12 to $96.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.15 to $97.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.16 to $98.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  12. The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.